Bortezomib With or Without Docetaxel in Treating Patients With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Bortezomib
Related studies linked through entity extraction aliases.
A Study to Assess Two Different Strategies of Combining Dexamethasone and VELCADE
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
A Study of PS-341 Given to Patients With Multiple Myeloma Who Experienced Progressive Disease After Receiving Dexamethasone in M34101-039
- Status
- COMPLETED
- Phase
- PHASE3
Bortezomib With or Without Irinotecan in Treating Patients With Cancer of the Gastroesophageal Junction or Stomach
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib in Treating Patients With Advanced Cancer and Kidney Dysfunction
- Status
- COMPLETED
- Phase
- PHASE1
Bortezomib With or Without Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib in Treating Patients With Metastatic or Recurrent Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib Plus Gemcitabine and Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
PS-341 (VELCADE™) Versus High-Dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Bortezomib in Treating Patients With Waldenstrom's Macroglobulinemia
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib in Treating Patients With Advanced Non-small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Bortezomib in Treating Patients With Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Bortezomib and Carboplatin in Treating Patients With Recurrent or Progressive Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
- Status
- COMPLETED
- Phase
- PHASE1
PS-341 in Treating Women With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
PS-341 and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Bortezomib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Bortezomib in Treating Patients With Advanced or Metastatic Sarcoma
- Status
- COMPLETED
- Phase
- PHASE2
PS-341 in Treating Women With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
PS-341 in Treating Patients With Metastatic Malignant Melanoma
- Status
- COMPLETED
- Phase
- PHASE2